Rhythm Control in AF: Have We Reached the Last Frontier?
AF is a worldwide epidemic, affecting approximately 33 million people, and its rising prevalence is expected to account for increasing clinical and public health costs. AF is associated with an increased risk of MI, heart failure, stroke, dementia, chronic kidney disease and mortality. Preserving si...
Guardado en:
Autor principal: | Gheorghe-Andrei Dan |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Radcliffe Medical Media
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/89e0833035cd402797df4c1d51aaa7ef |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Sleep Apnoea and AF: Where Do We Stand? Practical Advice for Clinicians
por: Suneet Mittal, et al.
Publicado: (2021) -
Mobile Health for Cardiovascular Disease: The New Frontier for AF Management: Observations from the Huawei Heart Study and mAFA-II Randomised Trial
por: Yutao Guo, et al.
Publicado: (2020) -
Rhythm Control in Heart Failure Patients with Atrial Fibrillation
por: William Eysenck, et al.
Publicado: (2020) -
Challenges Associated with Interpreting Mechanisms of AF
por: Caroline H Roney, et al.
Publicado: (2020) -
Mapping and Imaging in Non-paroxysmal AF
por: Michael Ghannam, et al.
Publicado: (2019)